Generation Bio Price to Free Cash Flow Ratio 2020-2023 | GBIO
Historical price to free cash flow ratio values for Generation Bio (GBIO) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Generation Bio Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-04-26 |
2.90 |
|
0.00 |
| 2023-12-31 |
1.65 |
$-0.93 |
0.00 |
| 2023-09-30 |
3.79 |
$-0.89 |
0.00 |
| 2023-06-30 |
5.50 |
$-0.83 |
0.00 |
| 2023-03-31 |
4.30 |
$-1.72 |
0.00 |
| 2022-12-31 |
3.93 |
$-1.91 |
0.00 |
| 2022-09-30 |
5.31 |
$-1.92 |
0.00 |
| 2022-06-30 |
6.56 |
$-2.00 |
0.00 |
| 2022-03-31 |
7.34 |
$-1.97 |
0.00 |
| 2021-12-31 |
7.08 |
$-1.74 |
0.00 |
| 2021-09-30 |
25.07 |
$-2.86 |
0.00 |
| 2021-06-30 |
26.90 |
$-0.67 |
0.00 |
| 2021-03-31 |
28.46 |
$-3.21 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.193B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
